Clinical Trials in Multiple Locations, China
Locations / Multiple Locations, China
Delta Trials records 20 clinical trials conducted in Multiple Locations, China, making it a notable site of clinical research activity. These trials across 26 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Multiple Locations has changed over time.
20
Total Trials
26
Conditions
1
Terminated since 2020
Browse by condition (26 total)
- Type 2 diabetes mellitus 2 trialsAll Type 2 diabetes mellitus trials
- Carcinoma, hepatocellular 2 trialsAll Carcinoma, hepatocellular trials
- Prostate cancer 2 trialsAll Prostate cancer trials
- Diabetes mellitus 2 trialsAll Diabetes mellitus trials
- Monogenetic diabetes 1 trialAll Monogenetic diabetes trials
- All Metastatic castration-resistant prostate cancer trials
- Type1 diabetes mellitus 1 trialAll Type1 diabetes mellitus trials
- Angiography 1 trialAll Angiography trials
- Liver neoplasms 1 trialAll Liver neoplasms trials
- Peripheral artery disease 1 trialAll Peripheral artery disease trials
- Hypertension 1 trialAll Hypertension trials
- Continuous glucose monitoring 1 trialAll Continuous glucose monitoring trials
- Chronic kidney disease 1 trialAll Chronic kidney disease trials
- All Wet age-related macular degeneration trials
- Endometriosis 1 trialAll Endometriosis trials
- Pulmonary embolism 1 trialAll Pulmonary embolism trials
- All Multidetector computed tomography trials
- Other forms of diabetes mellitus 1 trialAll Other forms of diabetes mellitus trials
- Coronary artery disease 1 trialAll Coronary artery disease trials
- Bone metastases 1 trialAll Bone metastases trials